Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 3:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1585–1608 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Parkinson's Disease
Interventions: Skill-Based Exercise, Aerobic Exercise, Social Contact; Other
Lead sponsor: University of Southern California; Other
Eligibility: 30 Years to 85 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Hypertension, Left Ventricular Diastolic Dysfunction
Interventions: Nebivolol; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Dementia, Mild Cognitive Impairment
Interventions: RTMS, sham; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 55 Years to 99 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2025
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Preclinical Alzheimer's Disease, Alzheimer Disease, Prodromal Alzheimer's Disease
Interventions: AADvac1, Tau2; Drug
Lead sponsor: Paul S. Aisen; Other
Eligibility: 50 Years to 80 Years
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 7
States / cities: Phoenix, Arizona • San Francisco, California • Lexington, Kentucky + 4 more

Conditions: Mild Cognitive Impairment (MCI)
Interventions: Telerehabilitation Physical Activity Behavioral Intervention; Behavioral
Lead sponsor: Creighton University; Other
Eligibility: 19 Years to 90 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Stem Cell Transplantation, Ventricular Dysfunction, Left
Interventions: Lower dose mesenchymal stem cell (MSC) injection, Placebo, Higher dose MSC injection; Biological · Genetic
Lead sponsor: Joshua M Hare; Other
Eligibility: 21 Years to 80 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 2
States / cities: Miami, Florida • Baltimore, Maryland

Conditions: Cognitive Decline, Cognitive Change, Cognitive Impairment, Postoperative Delirium, Anesthesia; Reaction, Anesthesia; Adverse Effect
Interventions: Neurocognition Interventions; Combination Product
Lead sponsor: Stanford University; Other
Eligibility: 65 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2030
U.S. locations: 1
States / cities: Stanford, California

Conditions: Parkinson Disease, Mitochondrial
Interventions: Not listed
Lead sponsor: University of Washington; Other
Eligibility: 65 Years to 85 Years
Enrollment: 30 participants
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Alzheimer's Disease
Interventions: KarXT, KarX-EC, Placebo; Drug · Other
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 60 Years to 85 Years
Enrollment: 586 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 28
States / cities: Long Beach, California • Redlands, California • Basalt, Colorado + 24 more

Conditions: Cancer Survivor, Sexual Dysfunction, Sexuality and Reproductive Issues, Unspecified Adult Solid Tumor, Protocol Specific
Interventions: therapeutic testosterone, placebo; Drug · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: Female only
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 16
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Urbana, Illinois + 13 more

Conditions: Tetraplegia, Hypothermia, Mild Cognitive Impairment
Interventions: Midodrine hydrochloride; Drug
Lead sponsor: James J. Peters Veterans Affairs Medical Center; Federal
Eligibility: 18 Years to 68 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Cognitive Impairment
Interventions: Single Dose of VU319, Single Dose Placebo, Fed State, Fasted State, Dose Escalation of VU319, Placebo Dose Escalation; Drug · Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Neurogenic Incontinence, Dysfunctional Voiding
Interventions: Division of the filum terminal; Procedure
Lead sponsor: Nemours Children's Clinic; Other
Eligibility: 5 Years to 16 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Anorexia Nervosa, Major Depressive Disorder, Generalized Anxiety Disorder, Panic Disorder, Brain Injury
Interventions: Isoproterenol, Normal saline; Drug
Lead sponsor: Laureate Institute for Brain Research, Inc.; Other
Eligibility: 18 Years to 55 Years
Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: Tulsa, Oklahoma

Conditions: Chronic Kidney Disease, Cardiovascular Disease
Interventions: Lanthanum carbonate, placebo, Ascorbic Acid, Nitroglycerin, Flow-mediated dilation measurement, Aortic pulse-wave velocity, Endothelial cell collection; Drug · Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 40 Years to 79 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Gastrointestinal Disease, Gastrointestinal Dysfunction
Interventions: Biopsy imaged by Optical imaging device.; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Healthy, Obesity, Diabetes, Healthy Volunteers, Atherosclerosis
Interventions: MR Imaging Techniques - 1, MR Imaging Techniques - 2, MR Imaging Techniques - 3, MR Imaging Techniques - 4; Device
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 4,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2030
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Meibomian Gland Dysfunction (Disorder)
Interventions: localized heat therapy; Device
Lead sponsor: Sight Sciences, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Brecksville, Ohio

Conditions: Anxiety, Cancer Survivor, Cognitive Impairment, Depression, Distress, Fatigue, Malignant Female Reproductive System Neoplasm, Pain, Sexual Dysfunction
Interventions: Mindfulness-Based Stress Reduction; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older · Female only
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Mitral Insufficiency
Interventions: Pressure volume loop evaluation, cardiovascular magnetic resonance imaging, Cardiopulmonary exercise testing (CPET), Kansas City Cardiomyopathy Questionairre; Diagnostic Test
Lead sponsor: Atlantic Health System; Other
Eligibility: 18 Years and older · Male only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Morristown, New Jersey

Conditions: Alzheimer Disease, Mild Cognitive Impairment
Interventions: ReCODE Protocol; Behavioral
Lead sponsor: QuesGen Systems Inc; Other
Eligibility: 45 Years to 76 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 3
States / cities: San Rafael, California • Walnut Creek, California • Ashland, Oregon

Conditions: Upper Extremity Dysfunction, Lower Extremity Problem
Interventions: Decision aid; Other
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 89 Years
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 6
States / cities: Austin, Texas

Conditions: Depression
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: Not listed
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Alzheimer Disease, Mild Alzheimer Disease, MCI With Increased Risk for Alzheimer Disease, Cognitive Impairment, Mild
Interventions: Siponimod, Placebo; Drug
Lead sponsor: St. Joseph's Hospital and Medical Center, Phoenix; Other
Eligibility: 50 Years to 85 Years
Enrollment: 105 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Phoenix, Arizona

Search by objective public record fields.

Exercise Targeting Cognitive Impairment in Parkinson's Disease

Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of Heart

Repetitive Transcranial Magnetic Stimulation for Dementia

Alzheimer's Tau Platform: Master Protocol

Rural Veteran and Care Partner Walking Program

Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS)

Building a Platform for Precision Anesthesia in the Geriatric Surgical Patient

Measures of Mitochondria Dysfunction in PD

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors

Body Temperature in Persons With Tetraplegia When Exposed to Cold

Putative Cognitive Enhancer VU319

Treatment of Neurogenic Incontinence by Surgery to Cut the Filum Terminale

Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa

Phosphate Lowering in CKD Trial

Optical Imaging of Gastrointestinal Biopsy Samples and Their Correlation With Histology

New Heart Imaging Techniques to Evaluate Possible Heart Disease

TearCare MGX™ System With and Without Warming Hold

Mindfulness Intervention in Reducing Anxiety in Patients Who Have Been Treated for Gynecologic Cancer

Assessing the Relationship Between Symptoms and Mitral Regurgitnant. Severity

Reversal of Cognitive Decline (ReCODE) Study

Decision Aids Upper and Lower Extremity

Platelet Function in Patients Treated With SSRI and Non-SSRI Antidepressants

Repurposing Siponimod for Alzheimer's Disease